Federal contract award
1333ND21PNB640152
STANDARDS DEVELOPMENT FOR REGENERATIVE MEDICINE THERAPIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Commerce |
| Office | DEPT OF COMMERCE NIST |
| NAICS | 813920 — Professional Organizations |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $975.9K |
| Current contract value | $975.9K |
| Potential contract value / ceiling | $2.2M |
| Start date | May 3, 2021 |
| Current end date | May 2, 2024 |
| Potential end date | May 2, 2026 |
| Latest award activity | Mar 15, 2023 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 2, 2024 | P24007 | $115.5K | EXERCISE OPTION III |
| Oct 24, 2023 | P24006 | $0 | ADMIN MOD |
| Mar 15, 2023 | P23005 | $0 | WITHIN SCOPE CHANGES |
| Feb 9, 2023 | P23004 | $267.2K | EXERCISE OPTION II AND INCORPORATE CHANGES TO THE CURRENT OPTION YEAR I TASK 3. |
| May 24, 2022 | P22003 | $0 | UPDATE ACCOUNTING STRINGS |
| Apr 7, 2022 | P22002 | $359.4K | EXERCISE OPTION I RMTM & FLOW CYTOMETRY |
| Nov 30, 2021 | P22001 | $0 | EO 14042, CHANGE POC INFORMATION |
| May 3, 2021 | 0 | $349.4K | STANDARDS DEVELOPMENT FOR REGENERATIVE MEDICINE THERAPIES |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.